Finance

Beta
Lists
IMA:NASDAQ
ImageneBio Inc
$5.55
-1.42%
(-0.080) 1D
Jun 9, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IMA...
Open
$5.61
High
$5.62
Low
$5.55
Mkt. cap
62.60M
Avg. vol.
40.00K
Volume
53.00
52-wk high
$18.00
52-wk low
$3.94
EPS
-$5.50
Beta
0.72
Shares outstanding
11.28M
No. of employees
17
Open
$5.61
High
$5.62
Low
$5.55
Mkt. cap
62.60M
Avg. vol.
40.00K
Volume
53.00
52-wk high
$18.00
52-wk low
$3.94
EPS
-$5.50
Beta
0.72
Shares outstanding
11.28M
No. of employees
17
Analyst outlook
Analyst Ratings
Based on 3 analysts giving stock ratings to IMA in the past 3 months
Buy
Buy
2
Hold
0
Sell
1
12 month forecast
Based on 3 Wall Street analysts offering 12 month price targets for IMA in the last 3 months.
Highest
Current $5.55
$24.00 (+332.43%)
Average
$13.00 (+134.23%)
Lowest
$2.00 (-63.96%)
News stories
From sources across the web
About ImageneBio Inc
CEO-
Employees17
Founded-
Headquarters-
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
5.65M
15.56M
3.27M
5.96M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.70M
11.04M
5.23M
6.12M
Operating expense
7.36M
26.59M
8.50M
12.08M
Total operating expenses
7.36M
26.59M
8.50M
12.08M
Operating income
-7.36M
-26.59M
-8.50M
-12.08M
Other non operating income
-32.00K
1.84M
-1.12M
341.00K
EBT including unusual items
-7.58M
-24.85M
-7.18M
-10.61M
EBT excluding unusual items
-7.58M
-24.85M
-7.18M
-10.62M
Income tax expense
-
-74.00K
-276.00K
10.00K
Effective tax rate
-
0.30%
3.84%
-0.09%
Other operating expenses
-
-
-
-
Net income
-7.58M
-24.78M
-6.91M
-10.62M
Net profit margin
-
-
-
-
Earnings per share
-
-2.91
-
-0.95
Interest and investment income
-
-
2.44M
1.12M
Interest expense
-194.00K
-96.00K
-
-
Net interest expenses
-194.00K
-96.00K
2.44M
1.12M
Depreciation and amortization charges
-
-
-
-
EBITDA
-7.36M
-26.59M
-8.11M
-11.98M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more